The Cancer Immunology and Immunotherapy Centre (CIIC) is a collaborative grouping of academic and clinical research groups based at the University of Birmingham and the Queen Elizabeth Hospital Birmingham. They are collectively focused on developing internationally outstanding basic tumour immunology research and translating key discoveries into improvements in cancer treatment.
Also in 'Cancer Immunology and Immunotherapy Centre'
Cancer immunology research at the University of Birmingham
The future of cancer treatment
University of Birmingham scientists may have found a way to pull down the protective wall that surrounds tumours, potentially re-exposing them to the killing power of the immune system and immunotherapy treatments.
Research led by the University of Birmingham has discovered an important first step in the pathway for developing personalised medicine for the treatment of head and neck cancer.
Significant funding of over £3.8 million has been awarded to the Cancer Research UK (CRUK) Birmingham Centre, based at the University of Birmingham, to develop its clinical academic training programme.
View all news